Vitamin D in Pregnancy and Lactation

NCT01112891 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2014-12-16

No results posted yet for this study

Summary

Background: Vitamin D is vital throughout pregnancy and lactation for both maternal and infant health. Health Canada recommends women take the AI of 5ug/day of vitamin D during pregnancy, however, it is unknown how much vitamin D is necessary to ensure both mother and baby reach a vitamin D serum concentration of 25OHD\>75nmol/L.

Conditions

  • Vitamin D Deficiency

Interventions

DRUG

Vitamin D

10 ug/day Vitamin D as part of standard pre-natal vitamin supplement, taken from 18 weeks gestation to 6 months postpartum.

DRUG

Vitamin D3

25 ug/day Vitamin D as part of standard pre-natal vitamin supplement, taken from 18 weeks gestation to 6 months postpartum.

DRUG

Vitamin D

50 ug/day Vitamin D as part of standard pre-natal vitamin supplement, taken from 18 weeks gestation to 6 months postpartum.

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV
  • University of British Columbia

    lead OTHER

Principal Investigators

  • Tim Green, Dr. · University of British Columbia

  • Sheila M. Innis, Dr. · University of British Columbia

  • Michael R. Lyon, MD · University of British Columbia

  • Antonia W. Shand, Dr · University of British Columbia

  • Peter von Dadelszen, MD · University of British Columbia

  • Russ Freisen, MSc · University of British Columbia

  • Kaitlin March · University of British Columbia

  • Tina Li · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2012-08-31
Completion
2013-02-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01112891 on ClinicalTrials.gov